Back to Search
Start Over
Management Strategies of dermatomyositis during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)
- Source :
- Clinics in Dermatology
- Publication Year :
- 2020
- Publisher :
- Elsevier Inc., 2020.
-
Abstract
- In late 2019, the coronavirus disease 2019 (COVID-19) broke out in Wuhan and then spread over China, which greatly affected the medical practices and health care systems. With most of the hospital’s outpatient services closed, the routine clinical diagnosis and treatment for patients with dermatomyositis has been disturbed. We conducted telephone follow-up for 52 patients to know the changes in the condition and the continuation of drug therapy and to ensure the continuity, safety, and effectiveness of the treatment of patients with dermatomyositis during COVID-19.
- Subjects :
- Adult
Male
2019-20 coronavirus outbreak
medicine.medical_specialty
Telemedicine
China
Coronavirus disease 2019 (COVID-19)
Dermatology
Dermatomyositis
Article
Disease Outbreaks
Medication Adherence
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
Pharmacotherapy
Health care
medicine
Humans
Intensive care medicine
Aged
030203 arthritis & rheumatology
business.industry
SARS-CoV-2
Outbreak
COVID-19
Middle Aged
medicine.disease
Clinical diagnosis
Female
Dermatologic Agents
business
Subjects
Details
- Language :
- English
- ISSN :
- 18791131 and 0738081X
- Database :
- OpenAIRE
- Journal :
- Clinics in Dermatology
- Accession number :
- edsair.doi.dedup.....78b630fbe4ef99ce5b048899c90717e0